Conmed (CNMD) Tops Q1 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
CONMED Corporation Announces First Quarter 2019 Financial Results
April 24, 2019 4:01 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the first quarter of 2019.
First Quarter 2019 Highlights
Sales of $218.4 million increased 8.1% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 300 basis points of growth. Domestic revenue increased 10.1% year over year. International revenue increased 5.8% as reported and 8.3% in constant currency. Diluted net earnings per share (GAAP) were $0.04, compared to diluted net earnings per share of $0.37 in the first quarter of 2018.... More


